Existing Annotations Review

GO Term	Evidence	Action	Reason
GO:0005576 extracellular region	IEA GO_REF:0000120	ACCEPT	Summary: Automated subcellular-location annotation (UniProt "Secreted") consistent with the experimentally established secretion of Fel d 1. Chain 2 is found in saliva and sebaceous gland secretions, with sebaceous glands being the main production site. Reason: Fel d 1 is a secreted secretoglobin; localization of chain 2 to the extracellular region is well supported by experimental localization to saliva and sebaceous gland secretions. Supporting Evidence: PMID:29643919 It is now recognized that the sebaceous glands, and not saliva, are the main production site
GO:0005509 calcium ion binding	IDA PMID:17543334 Structural characterization of the tetrameric form of the ma...	NEW	Summary: NEW (proposed). The tetrameric Fel d 1 crystal structure resolves two distinct calcium-binding sites, and UniProt records three calcium-coordinating residues (36, 72, 77) within chain 2. Calcium binding is the only ligand-binding activity experimentally demonstrated for Fel d 1 and is not currently captured in the GOA annotations for chain 2. Reason: Direct structural evidence supports calcium ion binding by the Fel d 1 tetramer, with chain 2 contributing calcium-coordinating residues. This is a well-supported molecular function that should be added. Supporting Evidence: PMID:17543334 structure of tetrameric Fel d 1 reveals two different calcium-binding sites file:FELCA/CH2/CH2-uniprot.txt Chelates calciums ions and may inhibit the activity of
GO:0001530 lipopolysaccharide binding	IDA PMID:23878318 Allergens as immunomodulatory proteins: the cat dander prote...	NEW	Summary: NEW (proposed). The assembled Fel d 1 protein directly binds the TLR4 agonist lipopolysaccharide (LPS) and acts as a lipid-transfer platform; chain 2 is an integral subunit of this complex. Notably, the enhancement is independent of glycosylation status, so chain 2's N-glycan is not required. Not in GOA. Reason: Herre et al. 2013 show Fel d 1 binds LPS; chain 2 contributes to the complex that carries this activity (UniProt assigns the same FUNCTION to both chains). Demonstrated chiefly in the context of human innate-immune amplification. Supporting Evidence: PMID:23878318 bind to the TLR4 agonist LPS file:FELCA/CH2/CH2-deep-research-falcon.md independent of glycosylation status
GO:0034145 positive regulation of toll-like receptor 4 signaling pathway	IDA PMID:23878318 Allergens as immunomodulatory proteins: the cat dander prote...	NEW	Summary: NEW (proposed). By binding LPS and transferring it to the TLR4 receptor complex, the Fel d 1 protein enhances TLR4 (and TLR2) signaling and innate immune (TNF-alpha) responses; chain 2 contributes as a subunit of the complex. Reason: Herre et al. 2013 showed Fel d 1 enhances TLR4/TLR2 signaling. This immunomodulatory activity is the proposed basis of allergenicity; chain 2 is part of the functional unit. Supporting Evidence: PMID:23878318 enhances signaling through the innate receptors TLR4 and TLR2

Core Functions

Calcium-binding, N-glycosylated subunit of the secreted Fel d 1 secretoglobin heterotetramer. Chain 2 (this protein) dimerizes with chain 1 via interchain disulfide bonds; the assembled tetramer binds calcium ions at sites to which chain 2 contributes coordinating residues, and functions in the extracellular space. The endogenous physiological role of the complex is not established.

Molecular Function:

calcium ion binding

Cellular Locations:

extracellular region

Supporting Evidence:

PMID:17543334
structure of tetrameric Fel d 1 reveals two different calcium-binding sites
file:FELCA/CH2/CH2-uniprot.txt
Chelates calciums ions and may inhibit the activity of

Immunomodulatory lipid-binding activity of the Fel d 1 complex, to which chain 2 contributes as a subunit. Fel d 1 binds bacterial lipopolysaccharide (LPS) and, via a CD14/MD2-dependent lipid-transfer mechanism, enhances TLR4/TLR2 innate immune signaling and pro-inflammatory (TNF-alpha) responses. The enhancement is independent of chain 2's glycosylation. This is the best-characterized molecular activity of the allergen, demonstrated chiefly in the context of human innate- immune amplification and allergic sensitization.

Molecular Function:

lipopolysaccharide binding

Directly Involved In:

positive regulation of toll-like receptor 4 signaling pathway

Cellular Locations:

extracellular region

Supporting Evidence:

PMID:23878318
bind to the TLR4 agonist LPS
PMID:23878318
enhances signaling through the innate receptors TLR4 and TLR2

References

GO_REF:0000120

Combined Automated Annotation using Multiple IEA Methods

PMID:29643919

An update on molecular cat allergens: Fel d 1 and what else? Chapter 1: Fel d 1, the major cat allergen.

Fel d 1 is a secreted secretoglobin (not a lipocalin) and the major cat allergen; its endogenous biological function is still unknown.

"The biological function of Fel d 1 is still unknown"
Sebaceous glands, rather than saliva, are the main production site of Fel d 1.

"It is now recognized that the sebaceous glands, and not saliva, are the main production site"

PMID:12851385

The crystal structure of the major cat allergen Fel d 1, a member of the secretoglobin family.

Fel d 1 is an all-alpha secretoglobin structurally similar to uteroglobin, with an internal asymmetric cavity that could bind an amphipathic endogenous ligand.

"Fel d 1 that could bind an endogenous ligand"

PMID:17543334

Structural characterization of the tetrameric form of the major cat allergen Fel d 1.

The Fel d 1 (1+2) tetramer crystal structure reveals two distinct calcium-binding sites, to which chain 2 contributes coordinating residues; PLA2 modulation via calcium sequestration is speculated by analogy to uteroglobin.

"structure of tetrameric Fel d 1 reveals two different calcium-binding sites"

PMID:23878318

Allergens as immunomodulatory proteins: the cat dander protein Fel d 1 enhances TLR activation by lipid ligands.

Fel d 1 binds the TLR4 agonist LPS and enhances TLR4/TLR2 signaling via a CD14/MD2-dependent lipid-transfer mechanism, independent of glycosylation.

"bind to the TLR4 agonist LPS"
Fel d 1 enhances TLR4/TLR2 innate immune signaling in response to lipid ligands.

"enhances signaling through the innate receptors TLR4 and TLR2"

PMID:34026578

Molecular diagnosis in cat allergy.

Fel d 1 binds fatty acids and steroids with good affinity (best ligands lauric acid and androsterone, a volatile steroid pheromone).

"binding with good affinity to some fatty acids and steroids, the best ligands being lauric acid"

file:FELCA/CH2/CH2-deep-research-falcon.md

Falcon deep research report for CH2 (Fel d 1 chain 2)

Suggested Experiments

Experiment: Perform untargeted lipidomics/metabolomics on ligands co-purifying with native Fel d 1 isolated from cat sebaceous secretions, and confirm direct binding and affinity of candidate ligands to recombinant Fel d 1 by isothermal titration calorimetry and co-crystallization.

Hypothesis: The Fel d 1 internal cavity binds a specific endogenous amphipathic ligand (e.g. a steroid, fatty acid, or pheromone).

Type: ligand identification / biophysical binding assay

Experiment: Reconstitute a calcium-dependent PLA2 activity assay in the presence and absence of folded recombinant Fel d 1 (and Ca2+-binding-site mutants in chain 2) to test for PLA2 inhibition and its calcium dependence.

Hypothesis: Calcium binding by the Fel d 1 tetramer enables sequestration that inhibits calcium-dependent phospholipase A2 activity.

Type: enzymatic / biochemical assay

Deep Research

Falcon

(CH2-deep-research-falcon.md)

Comprehensive Research Report: CH2 Gene (Fel d 1 Chain 2) in *Felis catus* Falcon

The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.

You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.

We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.

We are interested in where in or outside the cell the gene product carries out its function.

We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.

Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.

Comprehensive Research Report: CH2 Gene (Fel d 1 Chain 2) in Felis catus

Gene Identity and Nomenclature

The gene symbol CH2 in Felis catus (domestic cat) encodes the chain 2 polypeptide of Fel d 1 (Major allergen I polypeptide chain 2; UniProt accession P30440). Fel d 1 is the major cat allergen and a member of the secretoglobin family (also known as the uteroglobin family). The protein is encoded by two separate genes, CH1 (encoding chain 1) and CH2 (encoding chain 2), which are situated within a span of approximately 10,000 base pairs in the cat genome (brackett2022newfrontiersprecise pages 3-4). It is important to note that "CH2" in this context refers specifically to the Fel d 1 chain 2 gene in cats and should not be confused with immunoglobulin CH2 constant region domains or other genes bearing the same symbol in different organisms.

Protein Structure

Overall Architecture

Fel d 1 is a tetrameric protein (~35 kDa) composed of two non-covalently linked heterodimers, each consisting of chain 1 and chain 2 (gronlund2010themajorcat pages 1-2, brackett2022newfrontiersprecise pages 3-4). The crystal structure (PDB: 2EJN), solved in 2003, reveals an entirely α-helical fold consisting of 8 helices, which is a distinctive structural feature that sets it apart from many other allergens (gronlund2010themajorcat pages 2-3, herre2013allergensasimmunomodulatory pages 1-2). The tetrameric structure contains three well-defined calcium-binding sites and two internal hydrophobic pockets of different sizes (~350 Å³ and ~750 Å³) that are capable of harboring small ligands (gronlund2010themajorcat pages 2-3, brackett2022newfrontiersprecise pages 3-4).

Chain 2 (CH2 Gene Product) Specific Features

The CH2-encoded chain 2 has the following characteristics:

Molecular weight: ~10 kDa (gronlund2010themajorcat pages 1-2)
Length: Exists as tissue-specific isoforms — a shorter 90 amino acid version preferentially found in skin, and a longer 92 amino acid version expressed in salivary glands (gronlund2010themajorcat pages 1-2)
Glycosylation: Chain 2 carries the glycan moiety of the Fel d 1 protein, consisting of complex N-linked tri-antennary carbohydrate structures, accounting for 10–20% of the protein's mass. This makes chain 2 a glycopeptide, in contrast to chain 1, which is a non-glycosylated polypeptide (popescu2021moleculardiagnosisin pages 2-4, gronlund2010themajorcat pages 1-2)
Disulfide bonds: Chain 2 is covalently linked to chain 1 through three inter-chain disulfide bonds to form an anti-parallel heterodimer (gronlund2010themajorcat pages 1-2)
Sequence homology: Chain 2 shows only 10–15% sequence homology with other uteroglobins (gronlund2010themajorcat pages 2-3)

By comparison, chain 1 (encoded by CH1) is a smaller, non-glycosylated polypeptide of ~8 kDa and 70 amino acids (gronlund2010themajorcat pages 1-2). T-cell epitope mapping studies have detected reactivity to peptides from both chains, though chain 1 showed the most frequent T-cell responses (gronlund2010themajorcat pages 3-3).

The following table summarizes the key properties of the CH2 gene product and the Fel d 1 complex:

Feature	Fel d 1 / whole protein	CH1 / chain 1	CH2 / chain 2	Evidence
Protein name	Major cat allergen Fel d 1	Encodes chain 1 of Fel d 1	Encodes chain 2 of Fel d 1; corresponds to UniProt P30440 major allergen I polypeptide chain 2	(gronlund2010themajorcat pages 1-2, brackett2022newfrontiersprecise pages 3-4)
Organism	Felis catus	Felis catus	Felis catus	(brackett2022newfrontiersprecise pages 3-4)
Gene names	Two genes: CH1 and CH2	CH1	CH2	(brackett2022newfrontiersprecise pages 3-4)
Protein family	Secretoglobin / uteroglobin family	Subunit of secretoglobin Fel d 1	Subunit of secretoglobin Fel d 1	(gronlund2010themajorcat pages 2-3, gronlund2010themajorcat pages 1-2, popescu2021moleculardiagnosisin pages 2-4)
Overall size / molecular weight	Tetrameric protein of ~35 kDa composed of two heterodimers	~8 kDa, 70 aa	~10 kDa, 90 aa in skin isoform or 92 aa in salivary gland isoform	(gronlund2010themajorcat pages 1-2, brackett2022newfrontiersprecise pages 3-4)
Chain composition	Two non-covalently linked heterodimers; each heterodimer contains chain 1 + chain 2	One polypeptide in each heterodimer	One polypeptide/glycopeptide in each heterodimer	(popescu2021moleculardiagnosisin pages 2-4, gronlund2010themajorcat pages 1-2)
Disulfide linkage	Chains are covalently linked within heterodimers	Linked to chain 2 by inter-chain disulfide bonds	Linked to chain 1 by 3 inter-chain disulfide bonds	(gronlund2010themajorcat pages 1-2)
Glycosylation	Fel d 1 contains 10%–20% complex N-linked carbohydrate	No glycan moiety specifically assigned	Carries the glycan moiety; complex N-linked tri-antennary carbohydrate; described as glycopeptide	(popescu2021moleculardiagnosisin pages 2-4, gronlund2010themajorcat pages 1-2)
Structural fold	All-alpha-helical secretoglobin; solved structure shows internal hydrophobic cavities and Ca2+-binding sites	Part of anti-parallel heterodimer	Part of anti-parallel heterodimer; contributes glycosylated chain to heterodimer	(gronlund2010themajorcat pages 2-3, brackett2022newfrontiersprecise pages 3-4, gronlund2010themajorcat pages 1-2)
Higher-order structure	Tetramer with two pockets of different sizes (~350 and ~750 Å^3); three calcium-binding sites reported in tetrameric form	Contributes to tetramer assembly	Contributes to tetramer assembly and ligand-binding architecture	(gronlund2010themajorcat pages 2-3)
Tissue expression sites	Produced in skin/sebaceous glands, salivary glands, lacrimal glands, anal/perianal glands, and anal sacs; spread to fur during grooming	Co-expressed in skin and salivary glands	Co-expressed in skin and salivary glands; shorter skin-associated form and longer salivary-gland form	(popescu2021moleculardiagnosisin pages 2-4, gronlund2010themajorcat pages 2-3, gronlund2010themajorcat pages 1-2, brackett2022newfrontiersprecise pages 2-3, satyaraj2019keepthecat pages 2-3)
Localization / secretion	Secreted extracellular protein; deposited on fur/hair and shed with dander and saliva; up to 60% of airborne Fel d 1 carried on small particles	Secreted as part of Fel d 1 complex	Secreted as part of Fel d 1 complex	(popescu2021moleculardiagnosisin pages 2-4, gronlund2010themajorcat pages 2-3, satyaraj2019keepthecat pages 2-3)
Proposed biological functions	Exact endogenous function unresolved; proposed roles include immunoregulation, epithelial/skin defense, intra-species chemical communication, pheromone or semiochemical transport, and lipid/steroid ligand binding	No chain-specific standalone function established; structural subunit of allergen	No chain-specific standalone function established; glycosylated structural subunit likely important for secretion/stability/ligand interactions of Fel d 1	(popescu2021moleculardiagnosisin pages 2-4, gronlund2010themajorcat pages 2-3)
Ligand-binding evidence	Binds fatty acids and steroids; reported affinity for lauric acid and androsterone; also binds microbial lipid ligands such as LPS/LTA in immunomodulatory studies	Not assigned independently	Not assigned independently, but contributes to whole-protein ligand-binding structure	(popescu2021moleculardiagnosisin pages 2-4, herre2013allergensasimmunomodulatory pages 1-2, herre2013allergensasimmunomodulatory pages 6-7)
Immunological significance	Major cat allergen; accounts for 60%–90% of cat dander allergenic activity; IgE recognized by ~90%–98% of cat-allergic subjects; strongest basophil activator among tested cat allergens	T-cell epitopes present; chain 1 reported to yield the most frequent T-cell responses	T-cell epitopes also present; chain 2 contributes IgE-reactive/allergenic heterodimer structure	(popescu2021moleculardiagnosisin pages 4-5, gronlund2010themajorcat pages 3-3, trifonova2023allergenicactivityof pages 8-11, trifonova2023allergenicactivityof pages 6-8)
Innate immune signaling activity	Enhances TLR2/TLR4 signaling by binding lipid ligands and increasing their availability to CD14/MD2-dependent receptor complexes; increases TNF-alpha responses	No independent chain-specific mechanism reported	No independent chain-specific mechanism reported	(herre2013allergensasimmunomodulatory pages 1-2, herre2013allergensasimmunomodulatory pages 6-7, herre2013allergensasimmunomodulatory pages 10-14)
Chain 1 vs chain 2 difference summary	Fel d 1 requires both chains for native heterodimer/tetramer formation	Smaller, non-glycosylated 70-aa chain; more frequent T-cell responses reported	Larger glycosylated 90–92-aa chain; carries carbohydrate moiety and shows tissue-specific length variation	(gronlund2010themajorcat pages 1-2, gronlund2010themajorcat pages 3-3)

Table: This table summarizes the verified identity, structure, localization, and proposed functions of Fel d 1 in cats, with emphasis on the CH2-encoded chain 2 subunit. It also highlights the main differences between chain 1 and chain 2 that are relevant for functional annotation.

Biological Function

Proposed Physiological Roles

The precise biological function of Fel d 1 in cats remains unresolved despite decades of research (popescu2021moleculardiagnosisin pages 2-4, gronlund2010themajorcat pages 2-3). Several hypotheses have been proposed based on structural homology, ligand-binding studies, and comparative biology:

Lipid and steroid transport: Fel d 1 binds with good affinity to fatty acids and steroids, with particular affinity for lauric acid (a cat pheromone involved in social interactions) and androsterone (a volatile steroid pheromone) (popescu2021moleculardiagnosisin pages 2-4). The internal hydrophobic cavities within the tetramer are consistent with a role in small-molecule transport.
Chemical communication and pheromone signaling: The binding properties of Fel d 1 mirror those of mouse androgen-binding protein (ABP), a structural homolog secreted in mouse saliva that is involved in mate selection and chemical communication among mice (brackett2022newfrontiersprecise pages 3-4). A pheromone/chemical signaling role has been proposed based on these parallels (satyaraj2019keepthecat pages 2-3).
Epithelium defense and immunoregulation: Based on homology with human Clara cell protein (CC16) and rabbit uteroglobin, both of which have immunoregulatory and epithelial protective functions, Fel d 1 may play a protective role in cat skin and mucosal surfaces (popescu2021moleculardiagnosisin pages 2-4, gronlund2010themajorcat pages 2-3).
Structural similarity to defensive toxins: Sequence homology and common structural features have been identified between Fel d 1 and a defensive toxin secreted by the brachial glands of the slow loris primate, suggesting a possible ancient defensive function (brackett2022newfrontiersprecise pages 3-4).

Immunomodulatory Activity

A key functional discovery is that Fel d 1 acts as an immunomodulatory protein (IMP) that enhances innate immune signaling through Toll-like receptors. Herre et al. (2013) demonstrated that Fel d 1 directly binds lipopolysaccharide (LPS) and enhances TLR4 and TLR2 signaling by approximately 15-fold in HEK293 cells (herre2013allergensasimmunomodulatory pages 1-2, herre2013allergensasimmunomodulatory pages 4-6). Unlike the house dust mite allergen Der p 2, Fel d 1 does not mimic the TLR4 co-receptor MD2 and does not bind stably to the TLR4/MD2 complex. Instead, it acts as a lipid transfer platform, increasing the availability of microbial lipid PAMPs (pathogen-associated molecular patterns) to the CD14/MD2-dependent receptor complexes (herre2013allergensasimmunomodulatory pages 1-2, herre2013allergensasimmunomodulatory pages 6-7). This enhancement requires both CD14 and MD2 co-receptors and is independent of glycosylation status (herre2013allergensasimmunomodulatory pages 6-7, herre2013allergensasimmunomodulatory pages 10-14). The functional consequence is increased production of pro-inflammatory cytokines, particularly TNF-α, in primary immune cells including bone marrow-derived macrophages and peripheral blood mononuclear cells (herre2013allergensasimmunomodulatory pages 10-14, herre2013allergensasimmunomodulatory pages 4-6). At low environmental LPS concentrations, Fel d 1 clusters with LPS to form larger complexes that promote greater clustering of TLR4-bearing lipid rafts, thereby lowering the activation threshold for innate immune responses (herre2013allergensasimmunomodulatory pages 14-17).

Tissue Expression and Localization

Fel d 1 is a secreted extracellular protein produced by multiple glandular tissues in cats:

Sebaceous glands (primary source) (popescu2021moleculardiagnosisin pages 2-4)
Anal sacs/perianal glands (popescu2021moleculardiagnosisin pages 2-4, brackett2022newfrontiersprecise pages 2-3)
Salivary glands (gronlund2010themajorcat pages 2-3, satyaraj2019keepthecat pages 2-3)
Lacrimal glands (gronlund2010themajorcat pages 2-3, brackett2022newfrontiersprecise pages 2-3)

Both chains are co-expressed in skin and salivary glands, with tissue-specific expression of chain 2 isoforms (90 AA in skin; 92 AA in salivary glands) (gronlund2010themajorcat pages 1-2). The allergen is distributed onto the cat's fur during grooming behavior and is subsequently shed into the environment with hair and dander. Up to 60% of airborne Fel d 1 molecules are carried by particles smaller than 5 microns (popescu2021moleculardiagnosisin pages 2-4, satyaraj2019keepthecat pages 2-3). Fel d 1 is found at highest concentrations in cat fur, with levels ranging from 1 to 1,770 μg/g, particularly in neck hair, at lower levels in saliva, and at minimal levels in urine (popescu2021moleculardiagnosisin pages 4-5).

Hormonal Regulation

Production of Fel d 1 is influenced by testosterone. Male cats produce 3–5 times less Fel d 1 after neutering, and production can be restored to pre-neutering levels with exogenous testosterone administration (popescu2021moleculardiagnosisin pages 4-5, satyaraj2019keepthecat pages 2-3). Kittens produce less Fel d 1 than adult cats, and females generally produce lower levels than intact males (brackett2022newfrontiersprecise pages 2-3). All cats produce Fel d 1 regardless of breed, age, hair length, sex, housing type, or body weight, though production varies significantly both between individual cats and within the same cat across different time periods (satyaraj2019keepthecat pages 1-2).

Allergenic Significance and Immune Pathways

Role as Major Cat Allergen

Fel d 1 is the dominant allergen from domestic cats, accounting for 60–90% of total allergenic activity in cat dander extracts (popescu2021moleculardiagnosisin pages 4-5). Approximately 90–98% of European cat-allergic subjects produce specific IgE antibodies to recombinant Fel d 1, and IgE reactivity to Fel d 1 accounts for approximately 88% of the total IgE response to cat allergens (popescu2021moleculardiagnosisin pages 4-5, gronlund2010themajorcat pages 3-3). Cat allergy affects 10–15% of adults and children, and allergy to cats is a major risk factor for asthma and rhinitis (brackett2022newfrontiersprecise pages 3-4, satyaraj2019keepthecat pages 2-3).

Comparative Allergenic Activity

A comprehensive study by Trifonova et al. (2023) directly compared the allergenic activity of purified cat allergen molecules using basophil activation testing. Fel d 1 was the most potent allergen, inducing basophil activation in 88% of patients at 0.1 ng/mL — the lowest tested concentration — with a plateau reached at 1 ng/mL (trifonova2023allergenicactivityof pages 8-11). Fel d 7 (lipocalin) and Fel d 4 (lipocalin) were also significant allergens, activating basophils in 65% and 59.2% of patients respectively (trifonova2023allergenicactivityof pages 8-11). Among patients with respiratory symptoms, Fel d 1 showed the highest mean IgE level at 64.8 kUA/L and was recognized by 97% of symptomatic patients (trifonova2023allergenicactivityof pages 6-8). The following table provides a comprehensive comparison:

Allergen	Biochemical name / family	Human IgE sensitization rate	Mean IgE level (kUA/L)	Relative basophil activation potency
Fel d 1	Uteroglobin / secretoglobin	60%–100% (Satyaraj 2019); 84% overall, 97% in respiratory-symptom subgroup (Trifonova 2023) (satyaraj2019keepthecat pages 2-3, trifonova2023allergenicactivityof pages 6-8)	64.8 overall; 77.8 respiratory+; 25.7 respiratory− (trifonova2023allergenicactivityof pages 3-6)	Highest; most allergenic; induced basophil activation in 88% of patients at 0.1 ng/mL and plateau at 1 ng/mL (trifonova2023allergenicactivityof pages 8-11, trifonova2023allergenicactivityof pages 6-8)
Fel d 2	Serum albumin	14%–54% (Satyaraj 2019); 26% overall, 30% respiratory+ (Trifonova 2023) (satyaraj2019keepthecat pages 2-3, trifonova2023allergenicactivityof pages 3-6)	31.9 overall; 46.1 respiratory+; 1.15 respiratory− (trifonova2023allergenicactivityof pages 3-6)	High IgE binding but lower clinical relevance than Fel d 1/Fel d 4/Fel d 7; active at low concentrations but less frequently recognized (trifonova2023allergenicactivityof pages 1-2, trifonova2023allergenicactivityof pages 11-12)
Fel d 3	Cystatin	10% (Satyaraj 2019); 44% overall, 49% respiratory+ (Trifonova 2023) (satyaraj2019keepthecat pages 2-3, trifonova2023allergenicactivityof pages 3-6)	3.4 overall; 4.2 respiratory+; 1.2 respiratory− (trifonova2023allergenicactivityof pages 3-6)	Low; not among the most potent basophil-activating cat allergens (trifonova2023allergenicactivityof pages 1-2, trifonova2023allergenicactivityof pages 11-12)
Fel d 4	Lipocalin	63% (Satyaraj 2019); 63% overall, 70% respiratory+ (Trifonova 2023) (satyaraj2019keepthecat pages 2-3, trifonova2023allergenicactivityof pages 3-6)	15.4 overall; 19.8 respiratory+; 4.1 respiratory− (trifonova2023allergenicactivityof pages 3-6)	High; moderate-to-strong allergenicity; activated basophils in 59.2% of patients with plateau between 0.1–100 ng/mL (trifonova2023allergenicactivityof pages 8-11, trifonova2023allergenicactivityof pages 6-8)
Fel d 5	Immunoglobulin A	38% (Satyaraj 2019) (satyaraj2019keepthecat pages 2-3)	Not reported in Trifonova 2023 (trifonova2023allergenicactivityof pages 3-6)	Not individually assessed in available Trifonova 2023 basophil summary (trifonova2023allergenicactivityof pages 8-11, trifonova2023allergenicactivityof pages 11-12)
Fel d 6	Immunoglobulin M	Unknown (Satyaraj 2019); 26% overall, 32% respiratory+ (Trifonova 2023) (satyaraj2019keepthecat pages 2-3, trifonova2023allergenicactivityof pages 3-6)	4.1 overall; 5.12 respiratory+; 0.13 respiratory− (trifonova2023allergenicactivityof pages 3-6)	Low; not among the most potent basophil-activating cat allergens (trifonova2023allergenicactivityof pages 1-2, trifonova2023allergenicactivityof pages 11-12)
Fel d 7	Lipocalin	38% (Satyaraj 2019); 63% overall, 68% respiratory+ (Trifonova 2023) (satyaraj2019keepthecat pages 2-3, trifonova2023allergenicactivityof pages 3-6)	25.15 overall; 33.5 respiratory+; 6.2 respiratory− (trifonova2023allergenicactivityof pages 3-6)	High; second only to Fel d 1 in many subjects; activated basophils in 65% of children at ≤1 ng/mL (trifonova2023allergenicactivityof pages 8-11, trifonova2023allergenicactivityof pages 6-8)
Fel d 8	Latherin-like protein	19% (Satyaraj 2019); 53% overall, 57% respiratory+ (Trifonova 2023) (satyaraj2019keepthecat pages 2-3, trifonova2023allergenicactivityof pages 3-6)	4.9 overall; 6.3 respiratory+; 1.65 respiratory− (trifonova2023allergenicactivityof pages 3-6)	Very low; at least 100-fold lower allergenic activity than Fel d 1, Fel d 4, or Fel d 7 (trifonova2023allergenicactivityof pages 12-13, trifonova2023allergenicactivityof pages 11-12)

Table: This table compares Fel d 1 through Fel d 8 using biochemical classification, reported human IgE sensitization rates, mean allergen-specific IgE levels, and relative basophil activation potency. It integrates Satyaraj 2019 background sensitization data with Trifonova 2023 molecular allergen and basophil-activation findings.

IgE-Mediated Allergic Cascade

The allergic mechanism proceeds through the classic Type I hypersensitivity pathway: initial allergen exposure triggers antigen-presenting cells to present antigenic peptides to T helper cells, which promote B lymphocyte switching to produce allergen-specific IgE antibodies (satyaraj2019keepthecat pages 1-2). These IgE antibodies bind to high-affinity FcεRI receptors on mast cells and basophils. Upon subsequent exposure, Fel d 1 crosslinks two or more IgE:FcεRI complexes, triggering degranulation and the release of inflammatory mediators including histamine, heparin, interleukins (IL-3, IL-4, IL-5), leukotrienes, and prostaglandins (satyaraj2019keepthecat pages 2-3). Inhaled Fel d 1 induces mast cell activation in the respiratory tract, resulting in airway constriction, increased mucous production, and coughing (satyaraj2019keepthecat pages 2-3).

Recent Developments and Therapeutic Approaches

CRISPR Gene Editing of CH1 and CH2

Brackett and colleagues demonstrated that CRISPR-Cas9 can target the Fel d 1 genes for deletion. Genomic DNA from 50 domestic cats was sequenced to identify conserved regions in CH1 and CH2 suitable for CRISPR targeting. A panel of 10 sgRNAs targeted to either chain 1 or chain 2 genes achieved editing efficiencies of 5–55% (by sequence decomposition) in immortalized feline kidney epithelial cells, with no evidence of off-target editing at predicted sites (brackett2022newfrontiersprecise pages 3-4). This represents the first step toward creating Fel d 1-free cats and may also serve as a tool for definitively determining the biological function of the allergen (brackett2022newfrontiersprecise pages 3-4).

Anti-Fel d 1 IgY Antibodies in Cat Food

Anti-Fel d 1 polyclonal egg IgY antibodies incorporated into cat food resulted in a 47% reduction in haircoat Fel d 1 levels compared to baseline (brackett2022newfrontiersprecise pages 2-3). Pilot studies showed a 29.57% average decrease in salivary allergen over 6 weeks (satyaraj2019keepthecat pages 6-7). This approach exploits the ability of oral IgY to neutralize active Fel d 1 in cat saliva before it is deposited on fur during grooming.

Anti-Fel d 1 Vaccines for Cats

Immunization of cats with a recombinant Fel d 1 conjugated to a virus-like particle induced strong IgG antibody responses, resulting in approximately 50% reduction in allergen detected in cat tear extracts and a ~30% decrease in allergic patient symptom severity (brackett2022newfrontiersprecise pages 2-3, satyaraj2019keepthecat pages 6-7).

Recombinant Hypoallergenic Vaccines for Humans

Trifonova et al. (2025) developed recombinant fusion proteins (PreS-Cat 1–5) containing non-allergenic peptides from the IgE-binding sites of Fel d 1, Fel d 4, and Fel d 7 fused to a hepatitis B virus PreS carrier. Two subcutaneous immunizations in rabbits induced equal (for Fel d 1) or superior (for Fel d 4 and Fel d 7) IgE-blocking antibodies compared to 6–15 immunizations with conventional allergen extract-based vaccines. PreS-Cat 5 and PreS-Cat 1 were identified as the most promising molecular vaccine candidates for allergen-specific immunotherapy of cat allergy.

Summary

The CH2 gene in Felis catus encodes the chain 2 subunit of Fel d 1, the dominant cat allergen belonging to the secretoglobin family. Chain 2 is a ~10 kDa glycopeptide of 90–92 amino acids that carries the N-linked carbohydrate moiety and is linked to chain 1 by three disulfide bonds to form the functional heterodimer. The native Fel d 1 exists as a tetramer with hydrophobic cavities capable of binding lipids and steroids. While the precise endogenous function of Fel d 1 remains unknown, convergent evidence supports roles in lipid/pheromone transport and chemical communication, with demonstrated immunomodulatory activity through TLR2/TLR4 enhancement via lipid binding. The protein is secreted from sebaceous, salivary, lacrimal, and perianal glands and distributed onto cat fur during grooming. As the major cat allergen recognized by >90% of cat-allergic individuals, Fel d 1 and specifically the CH2 gene have become targets for novel therapeutic interventions including CRISPR gene editing, dietary IgY neutralization, cat vaccination, and recombinant hypoallergenic human vaccines.

References

(brackett2022newfrontiersprecise pages 3-4): Nicole F. Brackett, Anna Pomés, and Martin D. Chapman. New frontiers: precise editing of allergen genes using crispr. Frontiers in Allergy, Jan 2022. URL: https://doi.org/10.3389/falgy.2021.821107, doi:10.3389/falgy.2021.821107. This article has 40 citations and is from a peer-reviewed journal.
(gronlund2010themajorcat pages 1-2): Hans Grönlund, Tiiu Saarne, Guro Gafvelin, and Marianne van Hage. The major cat allergen, fel d 1, in diagnosis and therapy. International Archives of Allergy and Immunology, 151:265-274, Oct 2010. URL: https://doi.org/10.1159/000250435, doi:10.1159/000250435. This article has 154 citations and is from a peer-reviewed journal.
(gronlund2010themajorcat pages 2-3): Hans Grönlund, Tiiu Saarne, Guro Gafvelin, and Marianne van Hage. The major cat allergen, fel d 1, in diagnosis and therapy. International Archives of Allergy and Immunology, 151:265-274, Oct 2010. URL: https://doi.org/10.1159/000250435, doi:10.1159/000250435. This article has 154 citations and is from a peer-reviewed journal.
(herre2013allergensasimmunomodulatory pages 1-2): Jurgen Herre, Hans Grönlund, Heather Brooks, Lee Hopkins, Lisa Waggoner, Ben Murton, Monique Gangloff, Olaniyi Opaleye, Edwin R. Chilvers, Kate Fitzgerald, Nick Gay, Tom Monie, and Clare Bryant. Allergens as immunomodulatory proteins: the cat dander protein fel d 1 enhances tlr activation by lipid ligands. The Journal of Immunology, 191:1529-1535, Aug 2013. URL: https://doi.org/10.4049/jimmunol.1300284, doi:10.4049/jimmunol.1300284. This article has 131 citations.
(popescu2021moleculardiagnosisin pages 2-4): Florin-Dan Popescu, Carmen Saviana Ganea, Carmen Panaitescu, and Mariana Vieru. Molecular diagnosis in cat allergy. World Journal of Methodology, 11:46-60, May 2021. URL: https://doi.org/10.5662/wjm.v11.i3.46, doi:10.5662/wjm.v11.i3.46. This article has 35 citations.
(gronlund2010themajorcat pages 3-3): Hans Grönlund, Tiiu Saarne, Guro Gafvelin, and Marianne van Hage. The major cat allergen, fel d 1, in diagnosis and therapy. International Archives of Allergy and Immunology, 151:265-274, Oct 2010. URL: https://doi.org/10.1159/000250435, doi:10.1159/000250435. This article has 154 citations and is from a peer-reviewed journal.
(brackett2022newfrontiersprecise pages 2-3): Nicole F. Brackett, Anna Pomés, and Martin D. Chapman. New frontiers: precise editing of allergen genes using crispr. Frontiers in Allergy, Jan 2022. URL: https://doi.org/10.3389/falgy.2021.821107, doi:10.3389/falgy.2021.821107. This article has 40 citations and is from a peer-reviewed journal.
(satyaraj2019keepthecat pages 2-3): Ebenezer Satyaraj, Harold James Wedner, and Jean Bousquet. Keep the cat, change the care pathway: a transformational approach to managing fel d 1, the major cat allergen. Allergy, 74:5-17, Sep 2019. URL: https://doi.org/10.1111/all.14013, doi:10.1111/all.14013. This article has 103 citations and is from a highest quality peer-reviewed journal.
(herre2013allergensasimmunomodulatory pages 6-7): Jurgen Herre, Hans Grönlund, Heather Brooks, Lee Hopkins, Lisa Waggoner, Ben Murton, Monique Gangloff, Olaniyi Opaleye, Edwin R. Chilvers, Kate Fitzgerald, Nick Gay, Tom Monie, and Clare Bryant. Allergens as immunomodulatory proteins: the cat dander protein fel d 1 enhances tlr activation by lipid ligands. The Journal of Immunology, 191:1529-1535, Aug 2013. URL: https://doi.org/10.4049/jimmunol.1300284, doi:10.4049/jimmunol.1300284. This article has 131 citations.
(popescu2021moleculardiagnosisin pages 4-5): Florin-Dan Popescu, Carmen Saviana Ganea, Carmen Panaitescu, and Mariana Vieru. Molecular diagnosis in cat allergy. World Journal of Methodology, 11:46-60, May 2021. URL: https://doi.org/10.5662/wjm.v11.i3.46, doi:10.5662/wjm.v11.i3.46. This article has 35 citations.
(trifonova2023allergenicactivityof pages 8-11): Daria Trifonova, Mirela Curin, Ksenja Riabova, Antonina Karsonova, Walter Keller, Hans Grönlund, Ulrika Käck, Jon R. Konradsen, Marianne van Hage, Alexander Karaulov, and Rudolf Valenta. Allergenic activity of individual cat allergen molecules. International Journal of Molecular Sciences, 24:16729, Nov 2023. URL: https://doi.org/10.3390/ijms242316729, doi:10.3390/ijms242316729. This article has 26 citations.
(trifonova2023allergenicactivityof pages 6-8): Daria Trifonova, Mirela Curin, Ksenja Riabova, Antonina Karsonova, Walter Keller, Hans Grönlund, Ulrika Käck, Jon R. Konradsen, Marianne van Hage, Alexander Karaulov, and Rudolf Valenta. Allergenic activity of individual cat allergen molecules. International Journal of Molecular Sciences, 24:16729, Nov 2023. URL: https://doi.org/10.3390/ijms242316729, doi:10.3390/ijms242316729. This article has 26 citations.
(herre2013allergensasimmunomodulatory pages 10-14): Jurgen Herre, Hans Grönlund, Heather Brooks, Lee Hopkins, Lisa Waggoner, Ben Murton, Monique Gangloff, Olaniyi Opaleye, Edwin R. Chilvers, Kate Fitzgerald, Nick Gay, Tom Monie, and Clare Bryant. Allergens as immunomodulatory proteins: the cat dander protein fel d 1 enhances tlr activation by lipid ligands. The Journal of Immunology, 191:1529-1535, Aug 2013. URL: https://doi.org/10.4049/jimmunol.1300284, doi:10.4049/jimmunol.1300284. This article has 131 citations.
(herre2013allergensasimmunomodulatory pages 4-6): Jurgen Herre, Hans Grönlund, Heather Brooks, Lee Hopkins, Lisa Waggoner, Ben Murton, Monique Gangloff, Olaniyi Opaleye, Edwin R. Chilvers, Kate Fitzgerald, Nick Gay, Tom Monie, and Clare Bryant. Allergens as immunomodulatory proteins: the cat dander protein fel d 1 enhances tlr activation by lipid ligands. The Journal of Immunology, 191:1529-1535, Aug 2013. URL: https://doi.org/10.4049/jimmunol.1300284, doi:10.4049/jimmunol.1300284. This article has 131 citations.
(herre2013allergensasimmunomodulatory pages 14-17): Jurgen Herre, Hans Grönlund, Heather Brooks, Lee Hopkins, Lisa Waggoner, Ben Murton, Monique Gangloff, Olaniyi Opaleye, Edwin R. Chilvers, Kate Fitzgerald, Nick Gay, Tom Monie, and Clare Bryant. Allergens as immunomodulatory proteins: the cat dander protein fel d 1 enhances tlr activation by lipid ligands. The Journal of Immunology, 191:1529-1535, Aug 2013. URL: https://doi.org/10.4049/jimmunol.1300284, doi:10.4049/jimmunol.1300284. This article has 131 citations.
(satyaraj2019keepthecat pages 1-2): Ebenezer Satyaraj, Harold James Wedner, and Jean Bousquet. Keep the cat, change the care pathway: a transformational approach to managing fel d 1, the major cat allergen. Allergy, 74:5-17, Sep 2019. URL: https://doi.org/10.1111/all.14013, doi:10.1111/all.14013. This article has 103 citations and is from a highest quality peer-reviewed journal.
(trifonova2023allergenicactivityof pages 3-6): Daria Trifonova, Mirela Curin, Ksenja Riabova, Antonina Karsonova, Walter Keller, Hans Grönlund, Ulrika Käck, Jon R. Konradsen, Marianne van Hage, Alexander Karaulov, and Rudolf Valenta. Allergenic activity of individual cat allergen molecules. International Journal of Molecular Sciences, 24:16729, Nov 2023. URL: https://doi.org/10.3390/ijms242316729, doi:10.3390/ijms242316729. This article has 26 citations.
(trifonova2023allergenicactivityof pages 1-2): Daria Trifonova, Mirela Curin, Ksenja Riabova, Antonina Karsonova, Walter Keller, Hans Grönlund, Ulrika Käck, Jon R. Konradsen, Marianne van Hage, Alexander Karaulov, and Rudolf Valenta. Allergenic activity of individual cat allergen molecules. International Journal of Molecular Sciences, 24:16729, Nov 2023. URL: https://doi.org/10.3390/ijms242316729, doi:10.3390/ijms242316729. This article has 26 citations.
(trifonova2023allergenicactivityof pages 11-12): Daria Trifonova, Mirela Curin, Ksenja Riabova, Antonina Karsonova, Walter Keller, Hans Grönlund, Ulrika Käck, Jon R. Konradsen, Marianne van Hage, Alexander Karaulov, and Rudolf Valenta. Allergenic activity of individual cat allergen molecules. International Journal of Molecular Sciences, 24:16729, Nov 2023. URL: https://doi.org/10.3390/ijms242316729, doi:10.3390/ijms242316729. This article has 26 citations.
(trifonova2023allergenicactivityof pages 12-13): Daria Trifonova, Mirela Curin, Ksenja Riabova, Antonina Karsonova, Walter Keller, Hans Grönlund, Ulrika Käck, Jon R. Konradsen, Marianne van Hage, Alexander Karaulov, and Rudolf Valenta. Allergenic activity of individual cat allergen molecules. International Journal of Molecular Sciences, 24:16729, Nov 2023. URL: https://doi.org/10.3390/ijms242316729, doi:10.3390/ijms242316729. This article has 26 citations.
(satyaraj2019keepthecat pages 6-7): Ebenezer Satyaraj, Harold James Wedner, and Jean Bousquet. Keep the cat, change the care pathway: a transformational approach to managing fel d 1, the major cat allergen. Allergy, 74:5-17, Sep 2019. URL: https://doi.org/10.1111/all.14013, doi:10.1111/all.14013. This article has 103 citations and is from a highest quality peer-reviewed journal.

📚 Additional Documentation

Notes

(CH2-notes.md)

Fel d 1 chain 2 (CH2, UniProt P30440) — curation notes

Curated alongside chain 1 (CH1, P30438) from the review article
PMC5891966 / PMID:29643919 (Bonnet et al. 2018, Allergy Asthma Clin Immunol,
"An update on molecular cat allergens: Fel d 1 and what else? Chapter 1: Fel d 1,
the major cat allergen"). See genes/FELCA/CH1/CH1-notes.md for the shared
Fel d 1 background.

Identity

UniProt P30440, FEL1B_FELCA, gene name CH2 (chain 2 / β-chain).
109 aa precursor; signal 1–17, mature chain 18–109 (~10–11 kDa).
Glycoprotein: N-linked glycosylation at Asn50 [UniProt CARBOHYD 50;
KW Glycoprotein]. This distinguishes chain 2 from chain 1 (which is not glycosylated).
Chain 2 pairs with chain 1 (CH1, P30438) via three interchain disulfide bonds to
form a heterodimer; two heterodimers assemble into the ~35–38 kDa Fel d 1
heterotetramer
PMID:29643919.
Three alternatively spliced isoforms: long (CH2L, salivary-gland preferential),
short (CH2S, skin-preferential), and a truncated form [UniProt ALTERNATIVE PRODUCTS
TISSUE SPECIFICITY].

Family / fold

Member of the secretoglobin (uteroglobin) family; contributes to the
all-α uteroglobin-like fold of the assembled allergen
PMID:29643919.
Note: chain 2 sits in a different PANTHER family (PTHR31708) than chain 1
(PTHR21226), so it did NOT receive the family-propagated "steroid binding"
IBA/IEA annotation that chain 1 did.

Molecular function (known vs inferred)

Calcium ion binding — experimentally supported. Chain 2 contributes three
calcium-coordinating residues (36, 72, 77); the tetramer crystal structure
resolves two distinct Ca2+-binding sites
PMID:17543334.
UniProt FUNCTION (shared with chain 1): "Chelates calciums ions and may inhibit
the activity of calcium-dependent phospholipase A2."
Phospholipase A2 modulation — speculation (uteroglobin analogy), as for chain 1
PMID:17543334.
Biological function genuinely unknown for the Fel d 1 complex
PMID:29643919.

Localization / expression

Secreted [UniProt SUBCELLULAR LOCATION: Secreted].
Saliva and sebaceous glands; long form preferentially in salivary gland, short
form preferentially in skin; sebaceous glands are the main Fel d 1 production site
PMID:29643919.
→ "extracellular region" (GO:0005576) is appropriate.

Curation decisions (existing GOA annotations)

GO:0005576 extracellular region (IEA, GO_REF:0000120) → ACCEPT (secreted).

NEW: GO:0005509 calcium ion binding (chain-2 Ca-coordinating residues; tetramer
structure) added and recorded as core molecular function in the extracellular region;
in vivo biological role + cavity ligand recorded as knowledge gaps (shared with CH1).

Key references

PMID:29643919 — review (curation target), full text in PMC.
PMID:12851385 — monomeric crystal structure; secretoglobin/uteroglobin fold; cavity.
PMID:17543334 — tetramer crystal structure; two Ca2+-binding sites; PLA2 speculation.
PMID:1946388 — Fel d 1 protein sequence + cDNA cloning (chain 2 sequence).
PMID:1572548 — genomic structure, alternative splicing and variants of chain 2.
PMID:1712068 — biochemical structure of the major cat allergen.
PMID:6747135 — Cat allergen 1 biochemical/antigenic/allergenic properties.

Update: Falcon deep research integration (CH2-deep-research-falcon.md)

Ran FutureHouse Falcon deep research for chain 2 (27 citations). Findings mirror
the CH1 deep research, since the documented activities are properties of the
assembled Fel d 1 tetramer to which chain 2 contributes (the deep research notes
"no independent chain-specific mechanism reported" for chain 2). Verified against
the same primary sources used for CH1:

LPS binding + TLR4/TLR2 enhancement (Herre 2013, PMID:23878318): Fel d 1 binds
LPS and enhances TLR4/TLR2 signaling via CD14/MD2-dependent lipid transfer;
enhancement is independent of glycosylation status (relevant since chain 2 is the
glycosylated chain) PMID:23878318.
→ Added NEW: lipopolysaccharide binding (GO:0001530) and positive regulation of
toll-like receptor 4 signaling pathway (GO:0034145), framed as chain 2's
contribution to the heterotetramer (UniProt places the same FUNCTION on both
P30438 and P30440).
Ligand binding: Fel d 1 binds fatty acids and steroids (lauric acid, androsterone)
PMID:34026578;
both chains form the hydrophobic cavity. Captured in description/knowledge gaps
rather than as a chain-2-specific MF.
Chain-2 specifics reaffirmed: glycosylated (N-linked tri-antennary), ~10 kDa,
tissue-specific length isoforms (skin short / salivary long), contributes
calcium-coordinating residues.

Newly added references

PMID:23878318 — Herre 2013 (LPS/TLR4 enhancement; glycosylation-independent).
PMID:34026578 — Popescu 2021 (fatty-acid/steroid ligand binding).
file:FELCA/CH2/CH2-deep-research-falcon.md — Falcon deep research report.

📄 View Raw YAML

id: P30440
gene_symbol: CH2
product_type: PROTEIN
status: DRAFT
taxon:
  id: NCBITaxon:9685
  label: Felis catus
description: >-
  Chain 2 (beta chain) of the major cat allergen Fel d 1, a secreted
  secretoglobin (uteroglobin-family) glycoprotein of the domestic cat. The
  mature ~92-residue chain 2 is N-glycosylated (Asn50) and pairs with chain 1
  (CH1) through three interchain disulfide bonds to form a heterodimer; two
  heterodimers associate non-covalently into the ~35-38 kDa Fel d 1
  heterotetramer. Chain 2 contributes calcium-coordinating residues to the
  tetramer's calcium-binding sites and forms part of the uteroglobin-like
  all-alpha fold enclosing an internal hydrophobic cavity. The assembled Fel d 1
  binds small hydrophobic ligands (fatty acids and steroids, e.g. lauric acid and
  the steroid pheromone androsterone) and bacterial lipopolysaccharide, and by a
  CD14/MD2-dependent lipid-transfer mechanism enhances TLR4/TLR2 innate immune
  signaling. It is secreted, produced chiefly by sebaceous glands and also found in
  saliva, with production regulated by testosterone; alternatively spliced long
  (salivary-gland-preferential) and short (skin-preferential) forms exist. Together
  with chain 1 it constitutes the dominant cat allergen, recognized by IgE in the
  great majority of cat-allergic people; its endogenous biological function in the
  cat is unresolved.
alternative_products:
- name: 1 (CH2L)
  id: P30440-1
- name: 2 (CH2S)
  id: P30440-2
  sequence_note: VSP_004249
- name: 3 (CH2ST, Truncated)
  id: P30440-3
  sequence_note: VSP_004248
existing_annotations:
- term:
    id: GO:0005576
    label: extracellular region
  evidence_type: IEA
  original_reference_id: GO_REF:0000120
  qualifier: located_in
  review:
    summary: >-
      Automated subcellular-location annotation (UniProt "Secreted") consistent
      with the experimentally established secretion of Fel d 1. Chain 2 is found
      in saliva and sebaceous gland secretions, with sebaceous glands being the
      main production site.
    action: ACCEPT
    reason: >-
      Fel d 1 is a secreted secretoglobin; localization of chain 2 to the
      extracellular region is well supported by experimental localization to
      saliva and sebaceous gland secretions.
    supported_by:
    - reference_id: PMID:29643919
      supporting_text: It is now recognized that the sebaceous glands, and not saliva, are the main production site
- term:
    id: GO:0005509
    label: calcium ion binding
  evidence_type: IDA
  original_reference_id: PMID:17543334
  qualifier: enables
  review:
    summary: >-
      NEW (proposed). The tetrameric Fel d 1 crystal structure resolves two
      distinct calcium-binding sites, and UniProt records three
      calcium-coordinating residues (36, 72, 77) within chain 2. Calcium binding
      is the only ligand-binding activity experimentally demonstrated for Fel d 1
      and is not currently captured in the GOA annotations for chain 2.
    action: NEW
    reason: >-
      Direct structural evidence supports calcium ion binding by the Fel d 1
      tetramer, with chain 2 contributing calcium-coordinating residues. This is
      a well-supported molecular function that should be added.
    supported_by:
    - reference_id: PMID:17543334
      supporting_text: structure of tetrameric Fel d 1 reveals two different calcium-binding sites
    - reference_id: file:FELCA/CH2/CH2-uniprot.txt
      supporting_text: Chelates calciums ions and may inhibit the activity of
- term:
    id: GO:0001530
    label: lipopolysaccharide binding
  evidence_type: IDA
  original_reference_id: PMID:23878318
  qualifier: enables
  review:
    summary: >-
      NEW (proposed). The assembled Fel d 1 protein directly binds the TLR4 agonist
      lipopolysaccharide (LPS) and acts as a lipid-transfer platform; chain 2 is an
      integral subunit of this complex. Notably, the enhancement is independent of
      glycosylation status, so chain 2's N-glycan is not required. Not in GOA.
    action: NEW
    reason: >-
      Herre et al. 2013 show Fel d 1 binds LPS; chain 2 contributes to the complex
      that carries this activity (UniProt assigns the same FUNCTION to both chains).
      Demonstrated chiefly in the context of human innate-immune amplification.
    supported_by:
    - reference_id: PMID:23878318
      supporting_text: bind to the TLR4 agonist LPS
    - reference_id: file:FELCA/CH2/CH2-deep-research-falcon.md
      supporting_text: independent of glycosylation status
- term:
    id: GO:0034145
    label: positive regulation of toll-like receptor 4 signaling pathway
  evidence_type: IDA
  original_reference_id: PMID:23878318
  qualifier: involved_in
  review:
    summary: >-
      NEW (proposed). By binding LPS and transferring it to the TLR4 receptor
      complex, the Fel d 1 protein enhances TLR4 (and TLR2) signaling and innate
      immune (TNF-alpha) responses; chain 2 contributes as a subunit of the complex.
    action: NEW
    reason: >-
      Herre et al. 2013 showed Fel d 1 enhances TLR4/TLR2 signaling. This
      immunomodulatory activity is the proposed basis of allergenicity; chain 2 is
      part of the functional unit.
    supported_by:
    - reference_id: PMID:23878318
      supporting_text: enhances signaling through the innate receptors TLR4 and TLR2
core_functions:
- description: >-
    Calcium-binding, N-glycosylated subunit of the secreted Fel d 1 secretoglobin
    heterotetramer. Chain 2 (this protein) dimerizes with chain 1 via interchain
    disulfide bonds; the assembled tetramer binds calcium ions at sites to which
    chain 2 contributes coordinating residues, and functions in the extracellular
    space. The endogenous physiological role of the complex is not established.
  molecular_function:
    id: GO:0005509
    label: calcium ion binding
  supported_by:
  - reference_id: PMID:17543334
    supporting_text: structure of tetrameric Fel d 1 reveals two different calcium-binding sites
  - reference_id: file:FELCA/CH2/CH2-uniprot.txt
    supporting_text: Chelates calciums ions and may inhibit the activity of
  locations:
  - id: GO:0005576
    label: extracellular region
  knowledge_gaps:
  - gap_statement: >-
      The endogenous biological function of Fel d 1 is undetermined: it is not
      known whether the protein acts in skin/epithelial barrier protection, in
      transport of a lipophilic ligand, or in another role.
    boundary: >-
      Established: Fel d 1 is a secreted secretoglobin heterotetramer with a
      uteroglobin-like fold, calcium-binding sites, and an internal amphipathic
      cavity. Unknown: the physiological process it serves in the cat.
    gap_kind:
    - BIOLOGY
    provenance:
    - reference_id: PMID:29643919
      supporting_text: The biological function of Fel d 1 is still unknown
  - gap_statement: >-
      The physiological ligand and the in-cat role of Fel d 1's ligand binding are
      unconfirmed. Candidate ligands (lauric acid, androsterone) and LPS binding
      are reported in vitro, but which ligand the protein carries in vivo, and to
      what biological end, is not established.
    boundary: >-
      Established: the secretoglobin cavity binds small hydrophobic ligands and
      Fel d 1 binds fatty acids, steroids and LPS in vitro. Unknown: the
      physiological ligand/cargo and the biological process this serves in the cat.
    gap_kind:
    - BIOLOGY
    provenance:
    - reference_id: PMID:12851385
      supporting_text: Fel d 1 that could bind an endogenous ligand
- description: >-
    Immunomodulatory lipid-binding activity of the Fel d 1 complex, to which chain 2
    contributes as a subunit. Fel d 1 binds bacterial lipopolysaccharide (LPS) and,
    via a CD14/MD2-dependent lipid-transfer mechanism, enhances TLR4/TLR2 innate
    immune signaling and pro-inflammatory (TNF-alpha) responses. The enhancement is
    independent of chain 2's glycosylation. This is the best-characterized molecular
    activity of the allergen, demonstrated chiefly in the context of human innate-
    immune amplification and allergic sensitization.
  molecular_function:
    id: GO:0001530
    label: lipopolysaccharide binding
  directly_involved_in:
  - id: GO:0034145
    label: positive regulation of toll-like receptor 4 signaling pathway
  supported_by:
  - reference_id: PMID:23878318
    supporting_text: bind to the TLR4 agonist LPS
  - reference_id: PMID:23878318
    supporting_text: enhances signaling through the innate receptors TLR4 and TLR2
  locations:
  - id: GO:0005576
    label: extracellular region
proposed_new_terms: []
suggested_questions:
- question: >-
    What is the endogenous amphipathic ligand (if any) that occupies the internal
    cavity of the Fel d 1 tetramer, and does chain 2 contribute to its binding?
  experts: []
- question: >-
    Does Fel d 1 modulate calcium-dependent phospholipase A2 activity in vivo, as
    has been speculated by analogy to uteroglobin?
  experts: []
- question: >-
    Do the alternatively spliced long (salivary) and short (skin) forms of chain 2
    confer any functional difference, or only tissue-specific expression?
  experts: []
suggested_experiments:
- hypothesis: >-
    The Fel d 1 internal cavity binds a specific endogenous amphipathic ligand
    (e.g. a steroid, fatty acid, or pheromone).
  description: >-
    Perform untargeted lipidomics/metabolomics on ligands co-purifying with native
    Fel d 1 isolated from cat sebaceous secretions, and confirm direct binding and
    affinity of candidate ligands to recombinant Fel d 1 by isothermal titration
    calorimetry and co-crystallization.
  experiment_type: ligand identification / biophysical binding assay
- hypothesis: >-
    Calcium binding by the Fel d 1 tetramer enables sequestration that inhibits
    calcium-dependent phospholipase A2 activity.
  description: >-
    Reconstitute a calcium-dependent PLA2 activity assay in the presence and
    absence of folded recombinant Fel d 1 (and Ca2+-binding-site mutants in chain 2)
    to test for PLA2 inhibition and its calcium dependence.
  experiment_type: enzymatic / biochemical assay
references:
- id: GO_REF:0000120
  title: Combined Automated Annotation using Multiple IEA Methods
  findings: []
- id: PMID:29643919
  title: 'An update on molecular cat allergens: Fel d 1 and what else? Chapter 1: Fel d 1, the major cat allergen.'
  findings:
  - statement: >-
      Fel d 1 is a secreted secretoglobin (not a lipocalin) and the major cat
      allergen; its endogenous biological function is still unknown.
    supporting_text: The biological function of Fel d 1 is still unknown
  - statement: Sebaceous glands, rather than saliva, are the main production site of Fel d 1.
    supporting_text: It is now recognized that the sebaceous glands, and not saliva, are the main production site
  reference_review:
    relevance: HIGH
    correctness: VERIFIED
    review_notes: >-
      PMC full text reviewed; this is the curation-target review and accurately
      summarizes Fel d 1 structure, secretoglobin family membership, expression
      and unknown function.
- id: PMID:12851385
  title: The crystal structure of the major cat allergen Fel d 1, a member of the secretoglobin family.
  findings:
  - statement: >-
      Fel d 1 is an all-alpha secretoglobin structurally similar to uteroglobin,
      with an internal asymmetric cavity that could bind an amphipathic endogenous
      ligand.
    supporting_text: Fel d 1 that could bind an endogenous ligand
  reference_review:
    relevance: HIGH
    correctness: VERIFIED
    review_notes: >-
      Abstract-only cache; establishes the secretoglobin/uteroglobin fold and the
      internal ligand-binding cavity shared by both Fel d 1 chains.
- id: PMID:17543334
  title: Structural characterization of the tetrameric form of the major cat allergen Fel d 1.
  findings:
  - statement: >-
      The Fel d 1 (1+2) tetramer crystal structure reveals two distinct
      calcium-binding sites, to which chain 2 contributes coordinating residues;
      PLA2 modulation via calcium sequestration is speculated by analogy to
      uteroglobin.
    supporting_text: structure of tetrameric Fel d 1 reveals two different calcium-binding sites
  reference_review:
    relevance: HIGH
    correctness: VERIFIED
    review_notes: >-
      Abstract-only cache; primary evidence for calcium ion binding by the Fel d 1
      tetramer (core_functions). PLA2 inhibition is explicitly framed as
      speculation.
- id: PMID:23878318
  title: 'Allergens as immunomodulatory proteins: the cat dander protein Fel d 1 enhances TLR activation by lipid ligands.'
  findings:
  - statement: >-
      Fel d 1 binds the TLR4 agonist LPS and enhances TLR4/TLR2 signaling via a
      CD14/MD2-dependent lipid-transfer mechanism, independent of glycosylation.
    supporting_text: bind to the TLR4 agonist LPS
  - statement: Fel d 1 enhances TLR4/TLR2 innate immune signaling in response to lipid ligands.
    supporting_text: enhances signaling through the innate receptors TLR4 and TLR2
  reference_review:
    relevance: HIGH
    correctness: VERIFIED
    review_notes: >-
      PMC full text reviewed; primary evidence for LPS binding and TLR4/TLR2
      enhancement by the Fel d 1 complex (to which chain 2 contributes). Surfaced
      by Falcon deep research; enhancement reported independent of glycosylation.
- id: PMID:34026578
  title: Molecular diagnosis in cat allergy.
  findings:
  - statement: >-
      Fel d 1 binds fatty acids and steroids with good affinity (best ligands lauric
      acid and androsterone, a volatile steroid pheromone).
    supporting_text: binding with good affinity to some fatty acids and steroids, the best ligands being lauric acid
  reference_review:
    relevance: HIGH
    correctness: VERIFIED
    review_notes: >-
      PMC full-text review; supports steroid/fatty-acid ligand binding by the Fel d 1
      cavity and the pheromone-transport hypothesis. Surfaced by Falcon deep research.
- id: file:FELCA/CH2/CH2-deep-research-falcon.md
  title: Falcon deep research report for CH2 (Fel d 1 chain 2)
  findings: []
  reference_review:
    relevance: HIGH
    correctness: VERIFIED
    review_notes: >-
      FutureHouse Falcon deep research (27 citations). Claims verified against the
      cited primary literature (Herre 2013, Popescu 2021) before use; the documented
      activities are complex-level, with no chain-2-specific mechanism reported.

CH2

Gene Description

Existing Annotations Review

Core Functions

References

Suggested Questions for Experts

Suggested Experiments

Deep Research

Falcon

Comprehensive Research Report: CH2 Gene (Fel d 1 Chain 2) in Felis catus

Gene Identity and Nomenclature

Protein Structure

Overall Architecture

Chain 2 (CH2 Gene Product) Specific Features

Biological Function

Proposed Physiological Roles

Immunomodulatory Activity

Tissue Expression and Localization

Hormonal Regulation

Allergenic Significance and Immune Pathways

Role as Major Cat Allergen

Comparative Allergenic Activity

IgE-Mediated Allergic Cascade

Recent Developments and Therapeutic Approaches

CRISPR Gene Editing of CH1 and CH2

Anti-Fel d 1 IgY Antibodies in Cat Food

Anti-Fel d 1 Vaccines for Cats

Recombinant Hypoallergenic Vaccines for Humans

Summary

📚 Additional Documentation

Notes

Fel d 1 chain 2 (CH2, UniProt P30440) — curation notes

Identity

Family / fold

Molecular function (known vs inferred)

Localization / expression

Curation decisions (existing GOA annotations)

Key references

Update: Falcon deep research integration (CH2-deep-research-falcon.md)

Newly added references

📄 View Raw YAML